Clinical Trials Browser

Has results × Keratosis, Actinic × 3-ingenyl angelate × Clear all

NCT01998984 2025-03-10

Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis

Phase 2 Completed

266 enrolled 15 charts

Keratosis, Actinic

NCT02361216 2025-03-10

Efficacy and Safety of Ingenol Mebutate Gel for Actinic Keratosis Applied on Large Area on Face, Scalp or Chest

Phase 3 Completed

729 enrolled 14 charts

Keratosis, Actinic

NCT01449513 2025-03-07

PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Reflectance Confocal Microscopy

Phase 1 Completed

24 enrolled 26 charts

Keratosis, Actinic

NCT01926496 2025-03-07

Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%

Phase 4 Completed

485 enrolled 17 charts

Keratosis, Actinic

NCT01787383 2025-02-24

A Simultaneous Treatment Regimen Compared to a Sequential Treatment Regimen With Ingenol Mebutate Gel 0.015% and 0.05% of Two Areas With Actinic Keratosis on Face/Scalp and Trunk/Extremities

Phase 3 Completed

200 enrolled 16 charts

Keratosis, Actinic

NCT02866695 2022-03-09

Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of AK on the Face in Solid Organ Transplant Recipients

Phase 4 Completed

20 enrolled 12 charts

Keratosis, Actinic

NCT02385318 2021-11-02

To Compare Safety and Efficacy of Perrigo's Drug Product Compared to an FDA Approved Drug Product in the Treatment of Actinic Keratosis

Phase 3 Completed

519 enrolled 11 charts

Keratosis, Actinic

NCT02459795 2021-11-02

To Compare Safety and Efficacy of Perrigo's Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis

Phase 3 Completed

469 enrolled 10 charts

Keratosis, Actinic

NCT02654769 2020-05-12

A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis

Phase 3 Completed

441 enrolled 9 charts

Keratosis, Actinic

NCT03200912 2020-01-14

An Equivalence Study of Generic Ingenol Mebutate Gel 0.015% and Picato Gel 0.015% in Subjects With Actinic Keratosis

Phase 3 Completed

507 enrolled 11 charts

Keratosis, Actinic

NCT02251652 2017-04-26

Safety and Efficacy of Ingenol Mebutate 0.05% Gel When Used After Cryotherapy in the Hypertrophic Actinic Keratoses

Phase 4 Completed

16 enrolled 5 charts

Keratosis, Actinic

NCT00916006 2015-04-02

A Multi-center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)

Phase 3 Completed

269 enrolled 9 charts

Keratosis, Actinic

NCT00742391 2015-03-06

A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations

Phase 3 Completed

255 enrolled 9 charts

Keratosis, Actinic

NCT00852137 2015-03-06

A Study to Evaluate the Pharmacokinetics of PEP005 (Ingenol Mebutate) Gel, 0.05%, When Applied in a Maximal Use Setting to the Dorsal Aspect of the Forearm in Patients With Actinic Keratosis

Phase 2 Completed

16 enrolled 9 charts

Keratosis, Actinic

NCT00915551 2015-03-06

A Multi-Center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)

Phase 3 Completed

278 enrolled 9 charts

Keratosis, Actinic

NCT00942604 2015-03-06

A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations

Phase 3 Completed

203 enrolled 8 charts

Keratosis, Actinic